MMPP

CAS No. 1895957-18-2

MMPP( —— )

Catalog No. M34338 CAS No. 1895957-18-2

MMPP is a novel VEGFR2 inhibitor with anti-inflammatory and potential anticancer activity, inhibits STAT3, inhibits angiogenesis via VEGFR2/AKT/ERK/NF-kappaB pathway, and can be used to alleviate myocardial injury.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 391 Get Quote
5MG 606 Get Quote
10MG 866 Get Quote
25MG 1260 Get Quote
50MG 1702 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MMPP
  • Note
    Research use only, not for human use.
  • Brief Description
    MMPP is a novel VEGFR2 inhibitor with anti-inflammatory and potential anticancer activity, inhibits STAT3, inhibits angiogenesis via VEGFR2/AKT/ERK/NF-kappaB pathway, and can be used to alleviate myocardial injury.
  • Description
    MMPP is an anti-inflammatory agent. MMPP prevents LPS-induced mortality by inhibiting the inflammatory response via STAT3 activity inhibition.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    JAK/STAT Signaling
  • Target
    STAT
  • Recptor
    STAT | VEGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1895957-18-2
  • Formula Weight
    270.32
  • Molecular Formula
    C17H18O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(=C/CC1=CC=C(OC)C=C1)\C2=CC(OC)=C(O)C=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Son DJ, et, al. Novel synthetic (E)-2-methoxy-4-(3-(4-methoxyphenyl) prop-1-en-1-yl) phenol inhibits arthritis by targeting signal transducer and activator of transcription 3. Sci Rep. 2016 Nov 15:6:36852.?
molnova catalog
related products
  • Stafib-1

    A potent, selective small molecule inhibitor of transcription factor STAT5b with Ki of 44 nM.

  • STAT5 inhibitor 17f

    A novel potent, selective inhibitor of phosphorylation and transcriptional activity of STAT5, but not STAT3, AKT, or Erk1/2 phosphorylation.

  • SC-99

    A novel selective STAT3 inhibitor that inhibits JAK2-STAT3 activation.